文献速递血栓与止血

临终患者住院于姑息治疗单元的出血风险:RHESO研究

Bleeding risk of terminally ill patients hospitalized in palliative care units: the RHESO study.
PubMed 文献 · J Thromb Haemost · 2017-02-17

该多中心前瞻性观察研究纳入法国22个姑息治疗单元的1199例晚期癌症或肺、心、神经疾病患者,3个月时临床相关出血累积发生率为9.8%(95%CI 8.3-11.6),癌症、近期出血、抗血栓预防和抗血小板治疗为独立危险因素。

要点

  • 3个月临床相关出血累积发生率为9.8%(95%CI 8.3-11.6),致命性出血23例。
  • 症状性深静脉血栓累积发生率为0.5%(95%CI 0.2-1.1),仅6例。
  • 癌症、近期出血、抗血栓预防和抗血小板治疗与3个月临床相关出血独立相关。

核心结论

  • 在姑息治疗患者中决定是否使用血栓预防措施时,应考虑到这些患者的高出血风险。

研究设计与样本

  • 前瞻性观察性研究,纳入法国22个姑息治疗单元中因晚期癌症或肺、心脏或神经疾病首次入院姑息治疗单元的1199例患者,中位年龄71岁,男性45.5%。

主要发现

  • 姑息治疗最常见原因为癌症(90.7%)。
  • 3个月时1087例患者(91.3%)死亡,116例患者至少发生一次临床相关出血(其中23例致命)。
  • 考虑死亡竞争风险后,临床相关出血累积发生率为9.8%(95%CI 8.3-11.6)。
  • 深静脉血栓发生于6例患者,累积发生率为0.5%(95%CI 0.2-1.1)。
  • 癌症、近期出血、抗血栓预防和抗血小板治疗与3个月临床相关出血独立相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Essentials Bleeding incidence as hemorrhagic risk factors are unknown in palliative care inpatients. We conducted a multicenter observational study (22 Palliative Care Units, 1199 patients). At three months, the cumulative incidence of clinically relevant bleeding was 9.8%. Cancer, recent bleeding, thromboprophylaxis and antiplatelet therapy were independent risk factors. SUMMARY: Background The value of primary thromboprophylaxis in patients admitted to palliative care units is debatable. Moreover, the risk of bleeding in these patients is unknown. Objectives Our primary aim was to assess the bleeding risk of patients in a real-world practice setting of hospital palliative care. Our secondary aim was to determine the incidence of symptomatic deep vein thrombosis and to identify risk factors for bleeding. Patients/Methods In this prospective, observational study in 22 French palliative care units, 1199 patients (median age, 71 years; male, 45.5%), admitted for the first time to a palliative care unit for advanced cancer or pulmonary, cardiac or neurologic disease were included. The primary outcome was adjudicated clinically relevant bleeding (i.e. a composite of major and clinically relevant non-major bleeding) at 3 months. The secondary outcome was symptomatic deep vein thrombosis. Results The most common reason for palliative care was cancer (90.7%). By 3 months, 1087 patients (91.3%) had died and 116 patients had presented at least one episode of clinically relevant bleeding (fatal in 23 patients). Taking into account the competing risk of death, the cumulative incidence of clinically relevant bleeding was 9.8% (95% confidence interval [CI], 8.3-11.6). Deep vein thrombosis occurred in six patients (cumulative incidence, 0.5%; 95% CI, 0.2-1.1). Cancer, recent bleeding, antithrombotic prophylaxis and antiplatelet therapy were independently associated with clinically relevant bleeding at 3 months. Conclusions Decisions regarding the use of thromboprophylaxis in palliative care patients should take into account the high risk of bleeding in these patients.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Tardy B, Picard S, Guirimand F, et al. Bleeding risk of terminally ill patients hospitalized in palliative care units: the RHESO study. J Thromb Haemost. 2017. PMID: 28035750. doi:10.1111/jth.13606

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。